Neuropace (NPCE)10% owner sold ~$49.5M
KCK LTD., 10% owner at Neuropace, sold ~$49.5M of Neuropace shares.
- ~$49.5M
- Approx. value · 5.27M sh @ $9.40
- Traded
- Feb 20, 2025
- Filed
- Feb 20, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 24, 2025InsiderOfficer sold ~$48K of NPCE shares in the open market
- Jan 29, 2025InsiderOfficer sold ~$1.5K of NPCE shares in the open market
- Jan 30, 2025InsiderOfficer sold ~$3K of NPCE shares in the open market
- Feb 20, 2025 · this disclosureInsider10% owner sold ~$49.5M of NPCE shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Neuropace
For Neuropace, OQRO holds 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NPCE page.
Other recent filings by KCK LTD., 10% owner
- SEC Form 4 at Neuropace (NPCE)Oct 28, 2024
- SEC Form 4 at Neuropace (NPCE)Oct 28, 2024
- SEC Form 4 at Neuropace (NPCE)Oct 24, 2024
- SEC Form 4 at Neuropace (NPCE)Oct 22, 2024
- SEC Form 4 at Neuropace (NPCE)Oct 22, 2024
The full history of KCK LTD., 10% owner is on the profile page.
How this filing works
Other disclosures at Neuropace
- USAspending.gov award recordOct 5, 2026
- SEC Form 13F-HRAug 14, 2026
- USAspending.gov award recordJun 9, 2026
- SEC Form 13F-HRMay 15, 2026
- USAspending.gov award recordMar 17, 2026
- USAspending.gov award recordMar 11, 2026
Everything OQRO holds on this company is on its NPCE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data